RCM Technologies (RCMT) Q3 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2027 earnings summary
12 Nov, 2026Executive summary
Q3 revenue rose 4.4% YoY to $73.4M; operating income increased to $4.5M from $3.9M and net income to $2.7M from $2.3M.
39-week revenue grew 7.4% to $250.3M and net income rose to $11.5M from $10.2M.
Q3 adjusted EBITDA increased 14.2% to $6.3M; 39-week adjusted EBITDA rose to $23.8M from $21.4M and adjusted diluted EPS to $2.01 from $1.73.
Financial highlights
Q3 gross profit increased 2.7% to $19.9M; SGA was $14.8M vs. $14.9M, and operating margin improved to 6.2% from 5.6%.
Q3 diluted GAAP EPS was $0.37 vs. $0.30; adjusted diluted EPS was $0.53 vs. $0.42.
39-week gross profit was $66.0M, up 3.7%; operating income was $18.4M vs. $17.1M.
39-week operating cash flow was $9.8M vs. $7.5M; capex was $0.5M vs. $1.4M.
Outlook and guidance
Management expects outsourcing demand to rise for complex, business-critical systems involving AI, Agentic AI, Quality by Design and automation, while customers prioritize ROI amid budget constraints.
Forward-looking priorities include service demand, revenue and cash flow, pipeline and potential project wins, and investment and growth.
Liquidity is expected to cover needs for at least 12 months; operating cash flow and the revolving facility are primary funding sources. Capital use is expected to focus on working capital; acquisitions may require debt or potentially dilutive securities.
Latest events from RCM Technologies
- Director elections, auditor ratification and executive pay headline the 2026 proxy vote.RCMT
Proxy filing - Q2 2026 revenue up 20% to $93.8M, net income $4.9M, strong Engineering growth, internal control remediation ongoing.RCMT
Q2 2026 - Revenue fell 1.7% to $83M, with net income at $3.8M and adjusted EBITDA up to $8.1M.RCMT
Q1 2026 - Double-digit revenue and profit growth, with robust cash flow and margin stability.RCMT
Q4 2025 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with focus on governance.RCMT
Proxy Filing - Healthcare and engineering drove Q3 gains, but net income and cash flow declined year-over-year.RCMT
Q3 2024 - Q2 revenue and EBITDA rose, led by engineering and healthcare, with strong cash flow and buybacks.RCMT
Q2 2024 - Q1 2025 saw 17% revenue growth, higher earnings, and strong cash flow with share repurchases.RCMT
Q1 2025 - 2024 revenue rose 5.8% but profit fell; double-digit EBITDA growth targeted for 2025.RCMT
Q4 2024